Arphra
Terminal
Monitor
Equities
Fixed Income
Macro & Cross-Asset
Portfolio
Research & AI
Search issuers, ETFs, macro…
⌘K
--:--:--
ET
SR
live
S&P 500
7,512.99
-0.55%
NASDAQ
29,968.13
-1.89%
DOW
51,999.67
+0.64%
VIX
16.41
+1.30%
US10Y
4.43
-0.92%
EUR/USD
1.1615
+0.20%
GOLD
4,355.5
+0.47%
WTI
75.90
-6.78%
BTC
65,667.9
-0.74%
S&P 500
7,512.99
-0.55%
NASDAQ
29,968.13
-1.89%
DOW
51,999.67
+0.64%
VIX
16.41
+1.30%
US10Y
4.43
-0.92%
EUR/USD
1.1615
+0.20%
GOLD
4,355.5
+0.47%
WTI
75.90
-6.78%
BTC
65,667.9
-0.74%
S&P 500
7,512.99
-0.55%
NASDAQ
29,968.13
-1.89%
DOW
51,999.67
+0.64%
VIX
16.41
+1.30%
US10Y
4.43
-0.92%
EUR/USD
1.1615
+0.20%
GOLD
4,355.5
+0.47%
WTI
75.90
-6.78%
BTC
65,667.9
-0.74%
S&P 500
7,512.99
-0.55%
NASDAQ
29,968.13
-1.89%
DOW
51,999.67
+0.64%
VIX
16.41
+1.30%
US10Y
4.43
-0.92%
EUR/USD
1.1615
+0.20%
GOLD
4,355.5
+0.47%
WTI
75.90
-6.78%
BTC
65,667.9
-0.74%
Monitor
Screen
Issuer
Bonds
FX
Folio
AI
Inbox
AKTS
Aktis Oncology, Inc.
Healthcare
Biotechnology
US
USD
Peers →
$22.63
Live
Jun 16, 2026
Watchlist
AI Brief
→
Market cap
$1.21B
52w range
14.72 – 29.16
P / E
—
EPS · FY 2025
$-1.19
Volume
543.97K
Revenue · FY 2025
$6.5M
+336.92% YoY
Overview
Fundamentals
Valuation
Market
Ownership & flow
Narrative & AI
Dividends
Corp actions
Explain this page
Arphra AI
Plain-English read on Aktis Oncology, Inc.’s valuation
…
No corporate actions
No dividend or split records loaded for AKTS-US.
Home
Markets
Search
Watch
AI